32.10
+1.74%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sanara Medtech
From its filings with the US Securities and Exchange Commission
Sanara Medtech is based in Fort Worth, Texas and is incorporated in Texas. Its shares trade on Nasdaq under the ticker SMTI. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $103.1m and a net loss of $37.6m. At that date it held total assets of $72.9m and shareholders' equity of $5.9m. By business, Soft Tissue Repair Products [Member] brought in 88.6% of revenue, followed by Bone Fusion Products [Member] at 11.4%.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 7 Apr 1994
- Employees
- 108
- Website
- sanaramedtech.com ↗
- Head office
- 1200 SUMMIT AVE, FORT WORTH, TX, 76102
- Incorporated in
- TX
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Ronald NixonExecutive Chairman of the Board, since 2019$855,758
- Mr. Seth YonPresident, Chief Executive Officer, Director, since 2025
- Ms. Elizabeth TaylorChief Financial Officer
- Mr. Suresh MuppallaPresident and Chief Executive Officer of Tissue Health Plus, LLC
- Mr. Jacob WaldropChief Operating Officer$518,219
- Ms. Ann SalamoneDirector$269,912
- Mr. Robert DeSutterIndependent Director$122,954
- Mr. Roszell MackIndependent Director$112,697
- Mr. Eric MajorIndependent Director$107,569
- Mr. Keith MyersIndependent Director$69,125
- Ms. Sara OrtweinIndependent Director$107,569
- Mr. Eric TanzbergerIndependent Director$117,825
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 17
- Environment
- 4
- Social
- 20
- Governance
- 27
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sanara Medtech Inc has a strong portfolio of innovative medical technologies and products, which gives them a competitive advantage in the market.
- The company has a dedicated and experienced management team that possesses excellent expertise in the healthcare industry.
- Sanara Medtech has established strong relationships with key stakeholders, including healthcare professionals, hospitals, and distributors, contributing to its market presence.
Weaknesses
- The company's heavy reliance on a limited number of suppliers may expose Sanara Medtech to potential supply chain disruptions.
- Sanara Medtech's current market share is relatively small compared to larger competitors, limiting its brand recognition and market reach.
- The company lacks diversification in its product offerings and heavily depends on a few key products for revenue generation.
Opportunities
- The growing demand for advanced wound care solutions presents significant growth opportunities for Sanara Medtech Inc.
- Expansion into international markets can help Sanara Medtech to tap into new customer bases and diversify its revenue streams.
- The increasing adoption of telemedicine and remote healthcare services provides an opportunity for the company to develop innovative virtual wound care solutions.
Threats
- The healthcare industry is highly regulated, which poses compliance challenges for Sanara Medtech and exposes the company to legal and regulatory risks.
- Intense competition from established medical technology companies and new entrants in the market may potentially erode Sanara Medtech's market share.
- Economic downturns and changes in healthcare policies and reimbursement models can impact the purchasing power of healthcare providers, affecting the demand for Sanara Medtech's products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.